• Innovator Brand Name - Darzalex
  • API - Daratumumab
  • Packaging - Single-Dose Vial
  • Strength - 100 mg/5 ml & 400 mg/20 ml
  • Manufacturer Name - Johnson & Johnson


Daratumumab is an anti-cancer medication indicated for the treatment of:

Multiple Myeloma: In the patient who had received at least three prior therapies.

Newly Diagnosed Multiple Myeloma: Patients who are not able for autologous stem cell transplant may receive Daratumumab with a combination of the melphalan, bortezomib, and prednisone.

As a Monotherapy: Darazalex can be also taken by the patients with relapsed and refractory multiple myeloma.

Daratumumab Dosage

You should receive Daratumumab Injection as an infusion into your vein (Intravenously) by your healthcare provider.

Daratumumab side effects
  • Some most common adverse reactions include fever, tiredness, nausea, diarrhea, shortness of breath, feeling week, decreased appetite, cold-like symptoms, chills, and dizziness.
  • Also, severe side effects of Darzalex (Daratumumab) include infusion reactions, vomiting, lung infection, decreased blood cell count and swollen hands, ankles, and feet.
Warnings and Precautions
  • In the case of Neutropenia should be monitored complete blood count periodically during the treatment.
  • Patients with previously Hepatitis B infection should talk with your healthcare provider. It can active the Hepatitis B infection again.
  • Darzalex contraindicated for the patient with a history of severe hypersensitivity.
  • Patients with thrombocytopenia should be monitored closely as well as monitor complete blood cells count while on Daratumumab.
  • Patients with Infusion reactions should interrupt the infusion of Daratumumab (Darzalex).
Supplied/Storage and handling

Care should be exercised in the handling of Darzalex (Daratumumab Injection). Darzalex should be retained in their genuine & original packaging in order to protect them from the light. Store permitted between 2-8°C (36-46°F).

Commonly asked questions:

Mannitol, Sodium Acetate Tri-hydrate, Glacial Acetic Acid, Sodium Chloride, Polysorbate 20 and Water for Injection are some Inactive Ingredients.

Daratumumab is an immunoglobulin G1 kappa (IgG1κ) human monoclonal antibody. Therefore it is not a chemotherapy medicine. It is a targeted therapy also known as immunotherapy.

Yes. The FDA must first approve generic drugs before they are marketed. The FDA requires that generic drugs must be as high in quality, and as strong, pure and stable as brand name drugs.

Daratumumab is either given in combination with other drugs or alone to treat multiple myeloma. Healthcare professionals give this medicine through intravenous infusion according to the prescribed dosage to the patients.

There is no data or case study on the overdose of Daratumumab, yet if one takes the overdose of Daratumumab, contact the doctor for worsening signs and symptoms and keep the patient under observation.

  • You can buy daratumumab from any authorized whole seller after getting prescription from a qualified doctor. It is always better to check the credential of the whole seller/supplier/exporter before buying the product.
  • The buyer should check the existing law in their home country before importing the product.

Patients can simply fill the order form or can send mail at info@ikrispharmanetwork.com. Patient can also send WhatsApp message to +91 8130290915. We will reply ASAP with the details of Pricing and procedure.
Note:- The order will be confirmed only after the receipt of Valid prescription of Clinician


All Trademark and Brand that appear on the website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. Daratumumab is a pharmaceutical drug that legally requires a medical prescription to be dispensed.

Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller and Pharmacies.